Index by author

March 1, 2017; Volume 58,Issue 3

  1. Guehl, Nicolas J.

    1. Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects
      Dustin W. Wooten, Nicolas J. Guehl, Eline E. Verwer, Timothy M. Shoup, Daniel L. Yokell, Nevena Zubcevik, Neil Vasdev, Ross D. Zafonte, Keith A. Johnson, Georges El Fakhri and Marc D. Normandin
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 484-491; DOI: https://doi.org/10.2967/jnumed.115.170910

  2. Haberkorn, Uwe

    1. Preclinical Evaluation of 18F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging
      Jens Cardinale, Martin Schäfer, Martina Benešová, Ulrike Bauder-Wüst, Karin Leotta, Matthias Eder, Oliver C. Neels, Uwe Haberkorn, Frederik L. Giesel and Klaus Kopka
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 425-431; DOI: https://doi.org/10.2967/jnumed.116.181768

  3. Halkar, Raghuveer

    1. Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial
      Ashesh B. Jani, Eduard Schreibmann, Peter J. Rossi, Joseph Shelton, Karen Godette, Peter Nieh, Viraj A. Master, Omer Kucuk, Mark Goodman, Raghuveer Halkar, Sherrie Cooper, Zhengjia Chen and David M. Schuster
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 412-418; DOI: https://doi.org/10.2967/jnumed.116.176057

  4. Hatt, Mathieu

    1. Radiomics in PET/CT: More Than Meets the Eye?
      Mathieu Hatt, Florent Tixier, Dimitris Visvikis and Catherine Cheze Le Rest
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 365-366; DOI: https://doi.org/10.2967/jnumed.116.184655
    2. Reliability of PET/CT Shape and Heterogeneity Features in Functional and Morphologic Components of Non–Small Cell Lung Cancer Tumors: A Repeatability Analysis in a Prospective Multicenter Cohort
      Marie-Charlotte Desseroit, Florent Tixier, Wolfgang A. Weber, Barry A. Siegel, Catherine Cheze Le Rest, Dimitris Visvikis and Mathieu Hatt
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 406-411; DOI: https://doi.org/10.2967/jnumed.116.180919

  5. Hauser, Stefan

    1. 68Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with 223Ra: Proof of Concept
      Hojjat Ahmadzadehfar, Kambiz Azgomi, Stefan Hauser, Xiao Wei, Anna Yordanova, Florian C. Gaertner, Stefan Kürpig, Holger Strunk and Markus Essler
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 438-444; DOI: https://doi.org/10.2967/jnumed.116.178533

  6. Heck, Matthias M.

    1. Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
      Shozo Okamoto, Anne Thieme, Jakob Allmann, Calogero D’Alessandria, Tobias Maurer, Margitta Retz, Robert Tauber, Matthias M. Heck, Hans-Juergen Wester, Nagara Tamaki, Wolfgang P. Fendler, Ken Herrmann, Christian H. Pfob, Klemens Scheidhauer, Markus Schwaiger, Sibylle Ziegler and Matthias Eiber
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 445-450; DOI: https://doi.org/10.2967/jnumed.116.178483

  7. Heltemes, Thad A.

    1. Fission-Produced 99Mo Without a Nuclear Reactor
      Amanda J. Youker, Sergey D. Chemerisov, Peter Tkac, Michael Kalensky, Thad A. Heltemes, David A. Rotsch, George F. Vandegrift, John F. Krebs, Vakho Makarashvili and Dominique C. Stepinski
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 514-517; DOI: https://doi.org/10.2967/jnumed.116.181040

  8. Herrmann, Ken

    1. Human Biodistribution and Radiation Dosimetry of 18F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway
      Martin J. Barrio, Claudio Spick, Caius G. Radu, Michael Lassmann, Uta Eberlein, Martin Allen-Auerbach, Christiaan Schiepers, Roger Slavik, Johannes Czernin and Ken Herrmann
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 374-378; DOI: https://doi.org/10.2967/jnumed.116.182394
    2. Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
      Shozo Okamoto, Anne Thieme, Jakob Allmann, Calogero D’Alessandria, Tobias Maurer, Margitta Retz, Robert Tauber, Matthias M. Heck, Hans-Juergen Wester, Nagara Tamaki, Wolfgang P. Fendler, Ken Herrmann, Christian H. Pfob, Klemens Scheidhauer, Markus Schwaiger, Sibylle Ziegler and Matthias Eiber
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 445-450; DOI: https://doi.org/10.2967/jnumed.116.178483

  9. Hojgaard, Liselotte

    1. Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging
      Dorthe Skovgaard, Morten Persson, Malene Brandt-Larsen, Camilla Christensen, Jacob Madsen, Thomas Levin Klausen, Søren Holm, Flemming Littrup Andersen, Annika Loft, Anne Kiil Berthelsen, Helle Pappot, Klaus Brasso, Niels Kroman, Liselotte Højgaard and Andreas Kjaer
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 379-386; DOI: https://doi.org/10.2967/jnumed.116.178970

  10. Holdhoff, Matthias

    1. Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma
      Martin A. Lodge, Matthias Holdhoff, Jeffrey P. Leal, Asim K. Bag, L. Burt Nabors, Akiva Mintz, Glenn J. Lesser, David A. Mankoff, Arati S. Desai, James M. Mountz, Frank S. Lieberman, Joy D. Fisher, Serena Desideri, Xiaobu Ye, Stuart A. Grossman, David Schiff and Richard L. Wahl
      Journal of Nuclear Medicine March 1, 2017, 58 (3) 393-398; DOI: https://doi.org/10.2967/jnumed.116.178434
« Previous (Pages : 5 6 7 8 9 10 11 12 13 14 ... 26) Next »
Back to top

In this issue